ATXN10 purified MaxPab mouse polyclonal antibody (B01P)
产品名称： ATXN10 purified MaxPab mouse polyclonal antibody (B01P)
英文名称： ATXN10 purified MaxPab mouse polyclonal antibody (B01P)
产品编号： H00025814-B01P
产品价格： null
产品产地： 台湾
品牌商标： Abnova
更新时间： null
使用范围：
亚诺法生技股份有限公司（Abnova)
- 联系人 :
- 地址 : 台湾台北市内湖区洲子街 108 号 9 楼
- 邮编 : 11493
- 所在区域 : 台湾
- 电话 : +886-920**1152 点击查看
- 传真 : 点击查看
- 邮箱 : sales@abnova.com.tw
- Specification
- Product Description:
- Mouse polyclonal antibody raised against a full-length human ATXN10 protein.
- Immunogen:
- ATXN10 (ABM87569.1, 1 a.a. ~ 475 a.a) full-length human protein.
- Sequence:
- MAAPRPPPARLSGVMVPAPIQDLEALRALTALFKEQRNRETAPRTIFQRVLDILKKSSHAVELACRDPSQVENLASSLQLITECFRCLRNACIECSVNQNSIRNLDTIGVAVDLILLFRELRVEQESLLTAFRCGLQFLGNIASRNEDSQSIVWVHAFPELFLSCLNHPDKKIVAYSSMILFTSLNHERMKELEENLNIAIDVIDAYQKHPESEWPFLIITDLFLKSPELVQAMFPKLNNQERVTLLDLMIAKITSDEPLTKDDIPVFLRHAELIASTFVDQCKTVLKLASEEPPDDEEALATIRLLDVLCEMTVNTELLGYLQVFPGLLERVIDLLRVIHVAGKETTNIFSNCGCVRAEGDISNVANGFKSHLIRLIGNLCYKNKDNQDKVNELDGIPLILDNCNISDSNPFLTQWVIYAIRNLTEDNSQNQDLIAKMEEQGLADASLLKKVGFEVEKKGEKLILKSTRDTPKP
- Host:
- Mouse
- Reactivity:
- Human
- Storage Buffer:
- In 1x PBS, pH 7.2
- Storage Instruction:
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
- Quality Control Testing:
- Antibody reactive against mammalian transfected lysate.
- Applications
- Western Blot (Transfected lysate)
- Western Blot analysis of ATXN10 expression in transfected 293T cell line (H00025814-T01) by ATXN10 MaxPab polyclonal antibody.
Lane 1: ATXN10 transfected lysate(52.25 KDa).
Lane 2: Non-transfected lysate. - Protocol Download
- Entrez GeneID:
- 25814
- GeneBank Accession#:
- DQ896570.2
- Protein Accession#:
- ABM87569.1
- Gene Name:
- ATXN10
- Gene Alias:
- E46L,FLJ37990,SCA10
- Gene Description:
- ataxin 10
- Gene Ontology:
- Hyperlink
- Gene Summary:
- The autosomal dominant cerebellar ataxias (ADCAs) are a clinically and genetically heterogeneous group of disorders characterized by ataxia, dysarthria, dysmetria, and intention tremor. All ADCAs involve some degree of cerebellar dysfunction and a varying degree of signs from other components of the nervous system. A commonly accepted clinical classification (Harding, 1993) divides ADCAs into 3 different groups based on the presence or absence of associated symptoms such as brainstem signs or retinopathy. The presence of pyramidal and extrapyramidal symptoms and ophthalmoplegia makes the diagnosis of ADCA I, the presence of retinopathy points to ADCA II, and the absence of associated signs to ADCA III. Genetic linkage and molecular analyses revealed that ADCAs are genetically heterogeneous even within the various subtypes.[supplied by OMIM
- Other Designations:
- like mouse brain protein E46,spinocerebellar ataxia 10